{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:58:03Z","timestamp":1780901883013,"version":"3.54.1"},"reference-count":39,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13177","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:34:03Z","timestamp":1778232843000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["TPX2 as a prognostic biomarker and potential therapeutic target for malignant melanoma proliferation and metastasis"],"prefix":"10.3892","volume":"32","author":[{"given":"Fuqi","family":"Li","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, Guangdong 524023, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Maoming People's Hospital, Maoming, Guangdong 525000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Burn Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"key20260608090314_b1-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"245","key":"key20260608090314_b2-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1987-z","article-title":"Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy","volume":"17","author":"Xu","year":"2019","journal-title":"J Transl Med"},{"key":"key20260608090314_b3-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"510","DOI":"10.4149\/neo_2016_403","article-title":"Malignant melanoma: Diagnosis, treatment and cancer stem cells","volume":"63","author":"Kozovska","year":"2016","journal-title":"Neoplasma"},{"key":"key20260608090314_b4-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: Optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"key20260608090314_b5-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1634\/theoncologist.2012-0123","article-title":"U.S. Food and drug administration approval: Peginterferon-alfa-2b for the adjuvant treatment of patients with melanoma","volume":"17","author":"Herndon","year":"2012","journal-title":"Oncologist"},{"key":"key20260608090314_b6-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski","year":"2004","journal-title":"Physiol Rev"},{"key":"key20260608090314_b7-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1590\/s0365-05962013000100009","article-title":"Mechanisms regulating melanogenesis","volume":"88","author":"dos Santos Videira","year":"2013","journal-title":"An Bras Dermatol"},{"key":"key20260608090314_b8-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1039\/c7pp00430c","article-title":"Mechanisms of and variables affecting UVR photoadaptation in human skin","volume":"17","author":"Garmyn","year":"2018","journal-title":"Photochem Photobiol Sci"},{"issue":"842496","key":"key20260608090314_b9-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.842496","article-title":"Melanoma, melanin, and melanogenesis: The Yin and Yang relationship","volume":"12","author":"Slominski","year":"2022","journal-title":"Front Oncol"},{"key":"key20260608090314_b10-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1210\/en.2017-03230","article-title":"How UV light touches the brain and endocrine system through skin, and why","volume":"159","author":"Slominski","year":"2018","journal-title":"Endocrinology"},{"issue":"e92102","key":"key20260608090314_b11-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92102","article-title":"Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulation","volume":"2","author":"Badal","year":"2017","journal-title":"JCI Insight"},{"key":"key20260608090314_b12-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"key20260608090314_b13-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The gene ontology consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"key20260608090314_b14-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","article-title":"Novel genes associated with malignant melanoma but not benign melanocytic lesions","volume":"11","author":"Talantov","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"e10770","key":"key20260608090314_b15-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010770","article-title":"Integrative genome comparison of primary and metastatic melanomas","volume":"5","author":"Kabbarah","year":"2010","journal-title":"PLoS One"},{"key":"key20260608090314_b16-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"e74970","key":"key20260608090314_b17-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74970","article-title":"Advancements in the treatment of multiple myeloma","volume":"16","author":"Zavaleta-Monestel","year":"2024","journal-title":"Cureus"},{"issue":"181","key":"key20260608090314_b18-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.3390\/life13010181","article-title":"Review: The key factors to melanomagenesis","volume":"13","author":"Jitian Mihulecea","year":"2023","journal-title":"Life (Basel)"},{"key":"key20260608090314_b19-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20260608090314_b20-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/0008-5472.CAN-11-1971","article-title":"Tpx2 controls spindle integrity, genome stability, and tumor development","volume":"72","author":"Aguirre-Portoles","year":"2012","journal-title":"Cancer Res"},{"issue":"e162434","key":"key20260608090314_b21-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162434","article-title":"The UBE2C\/CDH1\/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells","volume":"133","author":"Zhang","year":"2023","journal-title":"J Clin Invest"},{"key":"key20260608090314_b22-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/s44321-024-00060-y","article-title":"Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma","volume":"16","author":"Wang","year":"2024","journal-title":"EMBO Mol Med"},{"issue":"116","key":"key20260608090314_b23-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00628-4","article-title":"The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun Signal"},{"key":"key20260608090314_b24-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/1878-0261.13602","article-title":"TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling","volume":"18","author":"Marug\u00e1n","year":"2024","journal-title":"Mol Oncol"},{"issue":"e111920","key":"key20260608090314_b25-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111920","article-title":"Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"key":"key20260608090314_b26-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1200\/JCO.2000.18.1.158","article-title":"Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma","volume":"18","author":"Middleton","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20260608090314_b27-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00008390-200108000-00012","article-title":"Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients","volume":"11","author":"Guven","year":"2001","journal-title":"Melanoma Res"},{"key":"key20260608090314_b28-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1158\/1078-0432.CCR-22-3145","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III\/IV melanoma: 5-year efficacy and biomarker results from CheckMate 238","volume":"29","author":"Larkin","year":"2023","journal-title":"Clin Cancer Res"},{"key":"key20260608090314_b29-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med"},{"key":"key20260608090314_b30-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(08)61033-8","article-title":"Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: Final results of EORTC 18991, a randomised phase III trial","volume":"372","author":"Eggermont","year":"2008","journal-title":"Lancet"},{"key":"key20260608090314_b31-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"key20260608090314_b32-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1038\/s44318-024-00240-z","article-title":"CEP192 localises mitotic Aurora-A activity by priming its interaction with TPX2","volume":"43","author":"Holder","year":"2024","journal-title":"EMBO J"},{"key":"key20260608090314_b33-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1158\/0008-5472.CAN-22-0631","article-title":"CHD1 promotes sensitivity to aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res"},{"key":"key20260608090314_b34-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s1097-2765(03)00392-7","article-title":"Structural basis of Aurora-A activation by TPX2 at the mitotic spindle","volume":"12","author":"Bayliss","year":"2003","journal-title":"Mol Cell"},{"key":"key20260608090314_b35-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/s0960-9822(03)00166-0","article-title":"A novel mechanism for activation of the protein kinase Aurora A","volume":"13","author":"Eyers","year":"2003","journal-title":"Curr Biol"},{"key":"key20260608090314_b36-ETM-32-1-13177","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41417-023-00607-0","article-title":"E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA","volume":"30","author":"Shen","year":"2023","journal-title":"Cancer Gene Ther"},{"issue":"1397","key":"key20260608090314_b37-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.3390\/cells13161397","article-title":"Contribution of AurkA\/TPX2 overexpression to chromosomal imbalances and cancer","volume":"13","author":"Polverino","year":"2024","journal-title":"Cells"},{"issue":"e202402978","key":"key20260608090314_b38-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202402978","article-title":"TPX2 lactylation is required for the cell cycle regulation and hepatocellular carcinoma progression","volume":"8","author":"Liu","year":"2025","journal-title":"Life Sci Alliance"},{"issue":"180","key":"key20260608090314_b39-ETM-32-1-13177","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02353-3","article-title":"Aurora kinases signaling in cancer: From molecular perception to targeted therapies","volume":"24","author":"Vats","year":"2025","journal-title":"Mol Cancer"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:03:18Z","timestamp":1780898598000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,5,8]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13177","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]}}}